{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T06:39:55Z","timestamp":1773729595173,"version":"3.50.1"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1111\/j.1574-695x.2007.00301.x","type":"journal-article","created":{"date-parts":[[2007,8,11]],"date-time":"2007-08-11T02:27:00Z","timestamp":1186799220000},"page":"201-211","source":"Crossref","is-referenced-by-count":15,"title":["Clinical application of<i>Clostridium botulinum<\/i>type A neurotoxin purified by a simple procedure for patients with urinary incontinence caused by refractory destrusor overactivity"],"prefix":"10.1093","volume":"51","author":[{"given":"Jae-Chul","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruhiko","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun-Jung","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Arimitsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumiko","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Takigawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouichi","family":"Takeshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Kumon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Oguma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1111\/j.1574-695X.2007.00301.x-BIB1","doi-asserted-by":"crossref","unstructured":"Arimitsu H , Inoue K , Sakaguchi Y , Lee JC , Fujinaga Y , Watanabe T , Ohyama T , Hirst R & Oguma K (2003) Purification of fully activated Clostridium botulinum serotype B toxin for treatment of patient with dystonia. Infect Immun 71: 1599\u00e2\u0080\u00931603.","DOI":"10.1128\/IAI.71.3.1599-1603.2003"},{"key":"10.1111\/j.1574-695X.2007.00301.x-BIB2","doi-asserted-by":"crossref","unstructured":"Dykstra DD , Sidi AA , Scott AB , Pagel JM & Goldish GD (1988) Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients. J Urol 139: 919\u00e2\u0080\u0093922.","DOI":"10.1016\/S0022-5347(17)42717-0"},{"key":"10.1111\/j.1574-695X.2007.00301.x-BIB3","unstructured":"Gao B & Tsan MF (2003) Recombinant human heat shock protein 60 does not induce the release of tumor necrosis factor from murine macrophages. J Biol Chem 25: 22523\u00e2\u0080\u009322529."},{"key":"10.1111\/j.1574-695X.2007.00301.x-BIB4","unstructured":"Griffiths D , Hofner K , van Mastrigt R , Rollema HJ , Spangberg A & Gleason D (1999) Standardization of lower urinary tract function: pressure-flow studies of voiding, urethral resistance, and urethral obstruction. International continence society subcommittee on standardization of terminology of pressure-flow studies. Neurourol Urodyn 16: 1\u00e2\u0080\u009318."},{"key":"10.1111\/j.1574-695X.2007.00301.x-BIB5","unstructured":"Haan LD , Hearn AR , Rivett AJ & Hirst TR (2002) Enhanced delivery of enogenous peptides into the class I antigen processing and presentation pathway. Infect Immun 70: 3249\u00e2\u0080\u00933258."},{"key":"10.1111\/j.1574-695X.2007.00301.x-BIB6","unstructured":"Inoue K , Fujinaga Y , Watanabe T , Ohyama T , Takeshi K , Moriishi K , Nakajima H , Inoue K & Oguma K (1996) Molecular composition of Clostridium botulinum type A PTXs. Infect Immun 64: 1589\u00e2\u0080\u00931594."},{"key":"10.1111\/j.1574-695X.2007.00301.x-BIB7","unstructured":"Jankovic J & Brin MF (1991) Therapeutic uses of botulinum toxin. N Engl J Med 324: 1186\u00e2\u0080\u00931194."},{"key":"10.1111\/j.1574-695X.2007.00301.x-BIB8","unstructured":"Kira S , Taketa K , Nogami Y & Hayatsu H (1995) A simplified technique for monitoring mutagenicity and benzo(a)pyrene content in mussels and their ambient water. Environ Toxicol Water Qua1 10: 167\u00e2\u0080\u0093172."},{"key":"10.1111\/j.1574-695X.2007.00301.x-BIB9","doi-asserted-by":"crossref","unstructured":"Lee JC , Yokota K , Arimitsu H , Hwang HJ , Sakaguchi Y , Cui J , Takeshi K , Watanabe T , Ohyama T & Oguma K (2005) Production of anti-neurotoxin antibody is enhanced by two subcomponents, HA1 and HA3b, of Clostridium botulinum type B 16S toxin- hemagglutinin. Microbiology 151: 3739\u00e2\u0080\u00933747.","DOI":"10.1099\/mic.0.28421-0"},{"key":"10.1111\/j.1574-695X.2007.00301.x-BIB10","unstructured":"Lew MF , Brashear A & Factor S (2000) The safety and efficacy of botulinum toxin type B in the treatment of patients with cervical dystonia: summary of three controlled clinical trials. Neurology 55: S29\u00e2\u0080\u0093S35."},{"key":"10.1111\/j.1574-695X.2007.00301.x-BIB11","unstructured":"Oguma K , Inoue K , Fujinaga Y , Yokota K , Watanabe T , Ohyama T , Takeshi K & Inoue K (1999) Structure and function of Clostridium botulinum PTX. J Toxicol-Toxin Rev 18: 17\u00e2\u0080\u009334."},{"key":"10.1111\/j.1574-695X.2007.00301.x-BIB12","unstructured":"Radziszewski P , Dobronski P & Borkowski A (2001) Treatment of the non-neurogenic storage and voiding disorders with the chemical denervation caused by botulinum toxin type A\u00e2\u0080\u0093A pilot study. Neurourol Urodyn abstract 20: 410\u00e2\u0080\u0093412."},{"key":"10.1111\/j.1574-695X.2007.00301.x-BIB13","first-page":"435","volume-title":"Bacterial Protein Toxins","author":"Sakaguchi","year":"1984"},{"key":"10.1111\/j.1574-695X.2007.00301.x-BIB14","doi-asserted-by":"crossref","unstructured":"Schmid DM , Sauermann P , Werner M et al. (2006) Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics. J Urol 176: 177\u00e2\u0080\u0093185.","DOI":"10.1016\/S0022-5347(06)00590-8"},{"key":"10.1111\/j.1574-695X.2007.00301.x-BIB15","unstructured":"Schurch B , Stohrer M , Kramer G , Schmid DM , Gaul G & Hauri D (2000) Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 164: 692\u00e2\u0080\u0093697."},{"key":"10.1111\/j.1574-695X.2007.00301.x-BIB16","unstructured":"Schurch B , de Seze M , Denys P et al. (2005) Botox\u00c2\u00ae detrusor hyperreflexia study team: botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol 174: 196\u00e2\u0080\u0093200."},{"key":"10.1111\/j.1574-695X.2007.00301.x-BIB17","doi-asserted-by":"crossref","unstructured":"Smith C , Nishiguchi J , O'Leary M , Yoshimura N & Chancellor MB (2005) Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra. Urology 65: 37\u00e2\u0080\u009341.","DOI":"10.1016\/j.urology.2004.08.016"},{"key":"10.1111\/j.1574-695X.2007.00301.x-BIB18","unstructured":"Sugii S & Sakaguchi G (1975) Molecular construction of Clostridium botulinum type A toxins. Infect Immun 12: 1262\u00e2\u0080\u00931270."},{"key":"10.1111\/j.1574-695X.2007.00301.x-BIB19","doi-asserted-by":"crossref","unstructured":"Wagner TH , Patrick DL , Bavendam TG , Martin ML & Buesching DP (1996) Quality of life of persons with urinary incontinence: development of a new measure. Urology 47: 67\u00e2\u0080\u009371.","DOI":"10.1016\/S0090-4295(99)80384-7"},{"key":"10.1111\/j.1574-695X.2007.00301.x-BIB20","doi-asserted-by":"crossref","unstructured":"Yahagi T , Nagao M , Seino Y , Matsushima T & Sugimura T (1977) Mutagenicities of N-nitrosamines on salmonella. Mutat Res 48: 121\u00e2\u0080\u0093129.","DOI":"10.1016\/0027-5107(77)90151-8"}],"container-title":["FEMS Immunology &amp; Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/femspd\/article-pdf\/51\/1\/201\/19170228\/51-1-201.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T19:00:37Z","timestamp":1556737237000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/femspd\/article-lookup\/doi\/10.1111\/j.1574-695X.2007.00301.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,10]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1574-695x.2007.00301.x","relation":{},"ISSN":["0928-8244","1574-695X"],"issn-type":[{"value":"0928-8244","type":"print"},{"value":"1574-695X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}